Bull&Bear | 908 Devices, Rapport Therapeutics Lead Bullish Surge; Viant Technology, James River Group Face Declines

In the realm of bullish stocks, 908 Devices (MASS) experienced a significant surge, rising by 95.96%. The company has strategically transitioned its operations, optimizing future growth by selling its desktop business to Repligen. This strategic divestment, along with a renewed focus on growth, has earned 908 Devices a buy rating.

Rapport Therapeutics (RAPP) also saw substantial growth, with its stock increasing by 39.72%. The company recently appointed Dr. Jeffrey Sevigny as Chief Medical Officer, a move aimed at advancing its clinical strategy and precision medicine initiatives.

Critical Metals (CRML) recorded a 36.53% increase. The company has announced a $1.5 million private placement to fund exploration activities, signaling a robust approach to expanding its resources.

Jiayin Group Inc. (JFIN) rose by 26.17%, marking its largest percentage gain since March 2021. The stock surged by more than 34%, reflecting investor confidence and strong market performance.

Puho Bio (PHH), a Chinese skincare company, experienced a notable three-day growth streak of 38.53%, and its stock rose by 23.53%. Its IPO was priced at $4, with a modest first-day increase of 1.75%.

Turning to bearish stocks, Viant Technology (DSP) saw a decline of 28.51% over three consecutive days, with a cumulative decrease of 31.89%. This drop came after the company released a fourth-quarter earnings report that fell short of expectations.

James River Group Holdings (JRVR) experienced a two-day decline of 28.37%, with a total drop of 29.09% over two days. The company's stock fell following the announcement of fourth-quarter earnings that missed market forecasts.

Paysafe (PSFE) decreased by 18.57% over two consecutive days, culminating in a 20.96% drop. Despite a 12% increase in transaction volume, the company's fourth-quarter revenue and weaker outlook for 2025 failed to meet expectations.

BRC Inc. (BRCC) fell by 16.34% over two days, with a cumulative decrease of 16.67%. The company maintained a hold rating, and investor sentiment was relatively cautious.

Repay Holdings (RPAY) witnessed a decline of 14.19% over two days, aggregating a loss of 15.26%. The drop was attributed to analysts highlighting concerns about client attrition and uncertainties around strategic review.